Outcome of Endometrial Cancer Clinical Trial
| Verified date | September 2012 |
| Source | Far Eastern Memorial Hospital |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | Taiwan: Institutional Review Board |
| Study type | Interventional |
Tumor invasion and metastasis are the major causes of cancer-related death. Some studies have found that histone methyltransferases, such as EZH2, specifically affect metastasis in breast, gastric and prostate cancer. The functional roles of other members of the HMT family such as G9a in cancer remain obscure. Therefore, the investigators will investigate whether G9a have a role in recurrence/metastasis of endometrial cancer.
| Status | Completed |
| Enrollment | 97 |
| Est. completion date | September 2012 |
| Est. primary completion date | July 2012 |
| Accepts healthy volunteers | No |
| Gender | Female |
| Age group | 20 Years and older |
| Eligibility |
Inclusion Criteria: - all cases with endometrial cancer underwent staging operation Exclusion Criteria: |
Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Basic Science
| Country | Name | City | State |
|---|---|---|---|
| Taiwan | Department of Obstetrics and Gynecology, Far-Eastern Memorial Hospital | Banqiao | New Taipei |
| Lead Sponsor | Collaborator |
|---|---|
| Far Eastern Memorial Hospital |
Taiwan,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | The role of G9a protein in endometrial cancer | We will correlate the G9a protein and outcome of endometrial cancer | overall survial, disease-free survival | No |